News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Jan 12, 2022 COVID-19 South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine Download Jan 10, 2022 COVID-19 Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa Download Jan 4, 2022 Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference Download Dec 31, 2021 COVID-19 Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine Download Dec 28, 2021 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India Download Dec 23, 2021 COVID-19 Novavax and SK bioscience Expand Manufacturing Agreement Download Dec 22, 2021 COVID-19 Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies Download Dec 21, 2021 COVID-19 Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study Download Dec 21, 2021 World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine Download Dec 17, 2021 COVID-19 Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine Download Dec 15, 2021 COVID-19 Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine Download Dec 15, 2021 StatementCOVID-19 Novavax Statement on PREVENT-19 Phase 3 Clinical Trial Results Publication in the New England Journal of Medicine Download Dec 13, 2021 COVID-19 Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates Download Dec 2, 2021 StatementCOVID-19 Novavax Statement on Omicron Variant Response Download Nov 24, 2021 Corporate and financeCOVID-19 Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore Download Nov 23, 2021 Novavax to Participate in Evercore ISI's 4th Annual HealthCONx Virtual Conference Download Nov 18, 2021 StatementCOVID-19 Novavax Statement on Publication of Positive Results from First Study of Co-administered COVID-19 and Influenza Vaccines Download Nov 17, 2021 COVID-19 Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization Download Nov 17, 2021 Corporate and financeCOVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines Download Nov 15, 2021 Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 Download Nov 10, 2021 StatementCOVID-19 Novavax Statement on UK and Mexico Phase 3 Clinical Trial Participants Considered Fully Vaccinated in the US Download Nov 4, 2021 Corporate and finance Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights Download Nov 4, 2021 Corporate and financeCOVID-19 Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization Download Nov 3, 2021 COVID-19 Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand Download Nov 1, 2021 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia Download Nov 1, 2021 Corporate and financeCOVID-19 Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency Download Oct 29, 2021 Corporate and financeCOVID-19 Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia Download Oct 27, 2021 Corporate and financeCOVID-19 Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom Download Oct 20, 2021 StatementCOVID-19 Novavax Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality Download Oct 19, 2021 StatementCOVID-19 Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World Vaccine Congress Europe Download Oct 18, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights on November 4, 2021 Download Oct 15, 2021 COVID-19Seasonal influenza Novavax to Participate in World Vaccine Congress Europe Download Oct 11, 2021 StatementCOVID-19 Complete PREVENT-19 Phase 3 Clinical Trial Results Manuscript for COVID-19 Vaccine Posted to medRxiv Download Oct 4, 2021 Corporate and finance Novavax Announces Leadership Appointment and Updates Download Sep 29, 2021 COVID-19 Novavax to Participate in Health Equity and Vaccine Confidence Panel at Maryland Life Sciences Bio Innovation Conference Download Sep 24, 2021 COVID-19 Novavax Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit to Uppsala County Download Sep 23, 2021 Seasonal influenza Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases Download Sep 23, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine Download Sep 23, 2021 Corporate and finance Novavax to Participate in Fireside Chat at the 2021 Cantor Virtual Global Healthcare Conference Download Sep 20, 2021 COVID-19 Novavax to Participate in Fireside Chat at Devex @ UNGA 76 Download Sep 17, 2021 StatementCOVID-19 Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S. Download Sep 16, 2021 COVID-19 Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents Download Sep 10, 2021 StatementCOVID-19 Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of Japan Download Sep 9, 2021 Corporate and finance Novavax to Participate in Upcoming September Conferences Download Sep 8, 2021 COVID-19 Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza Download Sep 7, 2021 Corporate and finance Novavax to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021 Download Aug 30, 2021 COVID-19 Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants Download Show 5102550100 per page«12345678»